Skip to content

Clinical trials

Observational Alzheimer Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20091
20111
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Tasmania2
Anne Murray1
Janssen-Cilag Pty Ltd1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Monash University1
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1
The Florey Institute of Neuroscience and Mental Health1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease9
Dementia7
Cognitive Dysfunction3
Dementia, Vascular1
Ischemic Stroke1
Memory Disorders1
Movement Disorders1
Nerve Degeneration1
Neurodegenerative Diseases1
Speech Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.